Skye Bioscience, Inc. Cash and Restricted Cash
Skye Bioscience, Inc. (SKYE) had Cash and Restricted Cash of $8.07 million as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Cash Flow › Cash
us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents · last filed 2026-08-14
- 2026-06-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.07M.
- 2026-03-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $8.15M.
- 2025-12-31: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $5.88M.
- 2025-09-30: Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $18.44M.
| Period end | Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents |
|---|---|
| 2026-06-30 | $8.07M 10-Q · filed 2026-08-14 |
| 2026-03-31 | $8.15M 10-Q · filed 2026-05-11 |
| 2025-12-31 | $5.88M 10-Q · filed 2026-08-14 |
| 2025-09-30 | $18.44M 10-Q · filed 2025-11-10 |
| 2025-06-30 | $23.84M 10-Q · filed 2026-08-14 |
| 2025-03-31 | $46.42M 10-Q · filed 2026-05-11 |
| 2024-12-31 | $68.42M 10-Q · filed 2026-08-14 |
| 2024-09-30 | $76.49M 10-Q · filed 2025-11-10 |
| 2024-06-30 | $83.20M 10-Q · filed 2025-08-07 |
| 2024-03-31 | $92.42M 10-Q · filed 2025-05-08 |
| 2023-12-31 | $10.34M 10-K · filed 2026-03-10 |
| 2023-09-30 | $14.21M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $558.03K 10-Q · filed 2024-08-09 |
| 2023-03-31 | $2.67M 10-Q · filed 2024-05-10 |
| 2022-12-31 | $1.25M 10-K · filed 2025-03-20 |
| 2022-09-30 | $419.96K 10-Q · filed 2023-11-14 |
| 2022-06-30 | $2.93M 10-Q · filed 2023-08-07 |
| 2022-03-31 | $6.01M 10-Q · filed 2023-05-12 |
| 2021-12-31 | $8.99M 10-K · filed 2024-03-22 |
| 2021-09-30 | $11.09M 10-Q · filed 2022-11-14 |
| 2021-06-30 | $5.19M 10-Q · filed 2022-08-15 |
| 2021-03-31 | $5.16M 10-Q · filed 2022-05-06 |
| 2020-12-31 | $2.47M 10-K · filed 2023-03-31 |
| 2020-09-30 | $4.23M 10-Q · filed 2021-11-10 |
| 2020-06-30 | $107.06K 10-Q · filed 2021-08-06 |
| 2020-03-31 | $568.40K 10-Q · filed 2021-05-07 |
| 2019-12-31 | $1.83M 10-K · filed 2022-03-28 |
| 2019-09-30 | $1.32M 10-Q · filed 2020-11-06 |
| 2019-06-30 | $2.81M 10-Q · filed 2020-08-13 |
| 2019-03-31 | $4.42M 10-Q · filed 2020-05-08 |
| 2018-12-31 | $1.86M 10-K · filed 2021-03-02 |
| 2018-09-30 | $1.06M 10-Q · filed 2019-11-14 |
| 2018-06-30 | $1.88M 10-Q · filed 2019-08-09 |
| 2018-03-31 | $2.95M 10-Q · filed 2019-05-10 |
| 2017-12-31 | $264.38K 10-K · filed 2020-03-23 |
| 2017-09-30 | $46.41K 10-Q · filed 2018-11-14 |
| 2017-06-30 | $146.36K 10-Q · filed 2018-08-10 |
| 2017-03-31 | $417.77K 10-Q · filed 2018-05-15 |
| 2016-12-31 | $102.32K 10-K · filed 2019-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| Boundless Bio, Inc. (BOLD) | United States | $0.059B | -0.88 |
| NOMAD POWER SOLUTIONS, INC. (NMAD) | United States | $0.058B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Annovis Bio, Inc. (ANVS) | United States | $0.056B | -1.58 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| HERON THERAPEUTICS, INC. /DE/ (HRTX) | United States | $0.055B | -2.38 |
| Clene Inc. (CLNN) | United States | $0.054B | -1.99 |